Literature DB >> 3486249

Growth-supporting activity of fragment Ba of the human alternative complement pathway for activated murine B lymphocytes.

F Praz, E Ruuth.   

Abstract

We have investigated the effects of cleavage of factor B by its activating enzyme, factor D, as well as its activation fragments Bb and Ba, on the growth of mouse spleen B lymphocytes preactivated by LPS. Neither factor B nor factor D show any growth-supporting activity when tested alone. The coaddition of factor B and factor D to serum-free cultures of LPS-preactivated B cell blasts increased the proliferation of the responding cells up to the level obtained by restimulation with LPS. Such growth-supporting activity was shown to be mediated by Ba, whereas Bb did not show any significant effect. Furthermore, this effect was not restricted to the LPS-preactivated B cell blasts; in fact, Ba also supported the growth of in vivo, activated B cell blasts of unprimed mice of the LPS-nonresponder C3H/HeJ strain. In contrast, Ba did not maintain growth of Con A-activated T cells or TCGF-dependent CTL cells. Taken together, these results describe the first biological activity of human Ba as a B cell stimulatory factor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486249      PMCID: PMC2188090          DOI: 10.1084/jem.163.5.1349

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS).

Authors:  D C Morrison; L F Kline
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

2.  Factor B of the alternative complement pathway on human lymphocytes.

Authors:  L Halbwachs; P J Lachmann
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

3.  Biosynthesis of complement components.

Authors:  G Fey; H R Colten
Journal:  Fed Proc       Date:  1981-05-15

4.  Inulin-induced activation of factor B in whole serum: description of structural modifications in the Ba fragment.

Authors:  C Davrinche; R Charlionet; C Rivat; A N Helal; G Lefranc
Journal:  Eur J Immunol       Date:  1984-10       Impact factor: 5.532

5.  Complement proteins and macrophages. II. The secretion of factor B by lipopolysaccharide-stimulated macrophages.

Authors:  A Miyama; Y Kawamoto; H Ichikawa; K Okamoto; S Hara; T Inoue
Journal:  Microbiol Immunol       Date:  1980       Impact factor: 1.955

6.  Isolation of cDNA clones for the human complement protein factor B, a class III major histocompatibility complex gene product.

Authors:  D E Woods; A F Markham; A T Ricker; G Goldberger; H R Colten
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

7.  The alternative pathway C3/C5 convertase: chemical basis of factor B activation.

Authors:  P H Lesavre; T E Hugli; A F Esser; H J Müller-Eberhard
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

8.  Third component of human complement: purification from plasma and physicochemical characterization.

Authors:  B D Tack; J W Prahl
Journal:  Biochemistry       Date:  1976-10-05       Impact factor: 3.162

9.  Fragments Ba and Bb derived from guinea pig factor B of the properdin system: purification, characterization, and biologic activities.

Authors:  J Hamuro; U Hadding; D Bitter-Suermann
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

10.  Mechanism of action of factor D of the alternative complement pathway.

Authors:  P H Lesavre; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

View more
  2 in total

1.  Abrogation of the alternative complement pathway by targeted deletion of murine factor B.

Authors:  M Matsumoto; W Fukuda; A Circolo; J Goellner; J Strauss-Schoenberger; X Wang; S Fujita; T Hidvegi; D D Chaplin; H R Colten
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

2.  cis and trans elements differ among mouse strains with high and low extrahepatic complement factor B gene expression.

Authors:  G Garnier; B Ault; M Kramer; H R Colten
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.